1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REGENXBIO INC
Regenxbio Inc XNAS: RGNX

Regenxbio Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. ...

Read More
9.08 -0.30 (-3.20%)
43.92% Fall from 52W High
710.2K
XNAS Volume

XNAS 12 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Regenxbio Inc is on 13 Mar 2026 for the purpose of Regenxbio Inc Fourth Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
20.8 / 100
Momentum Score
Technically Neutral
44.7 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
28
1Yr Price target upside is 206%
11 analysts

10

S

14

W

2

O

2

T

SWOT Analysis

Regenxbio Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..